Contraception and Headache
Version of Record online: 22 FEB 2013
© 2013 American Headache Society
Headache: The Journal of Head and Face Pain
Volume 53, Issue 2, pages 247–276, February 2013
How to Cite
MacGregor, E. A. (2013), Contraception and Headache. Headache: The Journal of Head and Face Pain, 53: 247–276. doi: 10.1111/head.12035
- Issue online: 22 FEB 2013
- Version of Record online: 22 FEB 2013
- Manuscript Accepted: 26 NOV 2012
Figure S1 Percent distribution of women aged 15-44 by contraceptive method: USA, 2006-2008.
Based on data from: Mosher W, Jones J. Use of contraception in the USA: 1982-2008. National Center for Health Statistics. Vital Health Stat 23. 2010;29:1-44.
Table S1 Formulations of currently marketed combined oral contraceptives.
Table S2 Risk of headache associated with COC containing 20 mcg of EE vs COC containing 30-50 mcg EE.
Table S3 Risk of headache leading to discontinuation of COC containing 20 mcg of EE vs COC containing 30-35 mcg of EE.
Table S4 Risk ratio of headache associated with COC use according to type of progestin.
Table S5 Risk ratio of headache leading to discontinuation of COC according to type of progestin.
Table S6 Risk ratio of migraine associated with COC use according to type of progestin.
Table S7 Risk ratio of migraine leading to discontinuation of COC according to type of progestin.
Table S8 Medical Eligibility Criteria (MEC) for Contraceptive Use of progestin-only and Copper-IUD contraceptives (based on US, WHO, and UK MEC).
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.